| Presented by: | The Cleveland Clinic Foundation Center for Continuing Education |
| Lecturer | William Carey, MD, Robert Gish, MD, Pierre Gholam, MD, Morris Sherman, MB BCh, PhD and Tram Tran, MD |
| Approximate duration: | 30 mins. |
| Summary points: | This audiovisual presentation discusses the predictive value of hepatitis B virus DNA in assessing hepatocellular cancer risk and defines the potential benefit of treatment in reducing this risk. |
| Accreditation: | The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s).
Expiration Date: January 15, 2011. |
| Other: | |
Risk of Hepatocellular Carcinoma in Hepatitis B and Prevention Through Treatment
